Specialty

NovaLign Orthopedics Inc. can now market its first product, a bone fixation system, after it received clearance from the Food and Drug Administration.

Abbott today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company’s fully bioabsorbable drug eluting coronary stent.

A five-year study confirms the long-term strength and durability of the Biodesign™ Hernia Graft, Cook Medical, a world leader in advanced tissue repair, announced today.

Ardian, Inc., developer of a breakthrough catheter-based medical device to treat hypertension, announced today that Medtronic, Inc., one of the world’s leading medical technology companies, has led a $47 million financing of the company.

CardiacAssist Inc. announced today that it has introduced a longer cannula set to cardiologists and cardiac surgeons to be used with its TandemHeart® cardiac-assist device: TandemHeart Transseptal Cannula Set—Enhanced Flow 72 (THTC-EF 72).

IlluminOss Medical Inc., a medical device company developing the innovative IlluminOss™ Photodynamic Bone Stabilization System for orthopedic surgery, today announced that it had been granted a CE Mark.

ACell, Inc. and Medline Industries, Inc. jointly announced today that Medline has signed an exclusive marketing and distribution agreement for ACell’s MatriStem™ Wound Care Matrix.

Covidien, a leading global provider of healthcare products, today announced that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert for adults.

Smith & Nephew Inc’s Advanced Wound Management division announced the U.S. launch of its next Negative Pressure Wound Therapy product, the new RENASYS GO, designed to address the needs of clinicians and their active, mobile patients.

Smith & Nephew, Inc. Orthopaedic Reconstruction & Trauma announced the introduction of VISIONAIRE Patient Matched instrumentation for use in total knee replacement surgery.

Smith & Nephew’s Endoscopy Division has announced the launch of the OSTEORAPTOR Anchor for repair in the hip and shoulder.

XTENT, Inc. today announced that it has received CE Mark approval for its CUSTOM NX drug-eluting stent (DES) System.

Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the deliverability of the Company’s market-leading intravascular ultrasound (IVUS) technology, the iLab® Ultrasound Imaging System.

The CATANIA™ Coronary Stent System with NanoThin Polyzene®-F offers sustained benefit in the treatment of de novo coronary lesions and maximizes endothelialization, while reducing restenosis, thrombogenicity, and the need for long-term dual-antiplatelet therapy.

Kinetic Concepts, Inc. announced that the German Federal Patent Court has ruled that a German patent licensed to KCI from Wake Forest related to KCI’s V.A.C.® technology is invalid.

Ethicon Women’s Health & Urology, a division of Ethicon, Inc., a Johnson & Johnson Company, announced that the GYNECARE PROLIFT+M™ Pelvic Floor Repair System is now available in the United States for use in surgery to treat pelvic organ prolapse.